|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:106-113
© 2007 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Pediatric and Congenital Cardiac Surgery Unit, Centro Gallucci, University of Padua Medical School, Padua, Italy
b Department of Cardiovascular Surgery, Ospedali Riuniti di Bergamo, Bergamo, Italy
c Department of Pediatric Cardiology, Ospedale G. Pasquinucci CREAS-CNR, Massa, Italy
d Department of Pediatric Cardiac Surgery, Azienda Ospedaliera S. Orsola-Malpighi, Bologna, Italy
e Department of Cardiac Surgery, Istituto Policlinico San Donato, Milano, Italy
f Department of Cardiac Surgery, Ospedale Niguarda Cà Granda, Milano, Italy
g Pediatric Cardiology and Cardiac Surgery, Second University, A.O. Monaldi, Naples, Italy
h Department of Cardiology, Centro Gallucci, University of Padua Medical School, Padua, Italy.
Read at the Eighty-sixth Annual Meeting of The American Association for Thoracic Surgery, Philadelphia, Pa, April 29–May 3, 2006.
Received for publication June 28, 2006; revisions received January 13, 2007; accepted for publication January 23, 2007. * Address for reprints: Giovanni Stellin, MD, Pediatric and Congenital Cardiac Surgery Unit, Centro Gallucci, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova Medical School, Via Giustiniani 2 – 35128 Padova, Italy. (Email: giovanni.stellin{at}unipd.it).
Objective: We have analyzed, in a clinical multicenter study, the effect of cardiac surgery in adults with congenital heart disease in Italy.
Methods: We collected clinical data from 856 patients aged 19 years or older who underwent surgical intervention from January 1, 2000, to December 31, 2004. Patients were divided into 3 surgical groups: group 1, palliation (3.1%); group 2, repair (69.7%); and group 3, reoperation (27.4%).
Results: Preoperatively, 34.6% of patients were in New York Heart Association class I, 48.4% were in class II, 14.2% were in class III, and 2.8% were in class IV. Sinus rhythm was present in 83%. There were 1179 procedures performed in 856 patients (1.37 procedures per patient), with a hospital mortality of 3.1%. Overall mean intensive care unit stay was 2.3 days (range, 1–102 days). Major complications were reported in 247 (28.8%) patients, and postoperative arrhythmias were the most frequent. At a mean follow-up of 22 months (range, 1 month–5.5 years; completeness, 87%), late death occurred in 5 (0.5%) patients. New York Heart Association class was I in 79.3%, II in 17.6%, and III in 2.9%, and only 1 (0.11%) patient was in class IV. Overall survival estimates are 82.6%, 98.9%, and 91.8% at 5 years for groups 1, 2, and 3, respectively. Freedom from adverse events at 5 years is 91% for acyanotic patients versus 63.9% for preoperative cyanotic patients (P < .0001).
Conclusions: Surgical intervention for congenital heart disease in adults is a safe and low-risk treatment. However, patients presenting with preoperative cyanosis show a higher incidence of late adverse events and complications.
Related Article
J. Thorac. Cardiovasc. Surg. 2007 134: 113.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |